Pure Financial Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$726K Sell
7,016
-172
-2% -$15.4K 0.01% 290
2026
Q1
$516K Buy
7,188
+202
+3% +$15.6K 0.01% 327
2025
Q4
$554K Buy
6,986
+377
+6% +$29.7K 0.01% 294
2025
Q3
$498K Buy
6,609
+80
+1% +$5.48K 0.01% 310
2025
Q2
$450K Buy
6,529
+3,516
+117% +$231K 0.01% 315
2025
Q1
$204K Buy
+3,013
New +$180K ﹤0.01% 371
2024
Q1
Sell
-2,552
Closed -$202K 315
2023
Q4
$202K Buy
+2,552
New +$182K 0.01% 293
2022
Q1
Sell
-2,341
Closed -$242K 224
2021
Q4
$242K Sell
2,341
-345
-13% -$31.9K 0.01% 190
2021
Q3
$228K Buy
+2,686
New +$225K 0.02% 179
2021
Q2
Sell
-3,374
Closed -$254K 198
2021
Q1
$254K Buy
3,374
+103
+3% +$7.5K 0.03% 163
2020
Q4
$223K Buy
+3,271
New +$213K 0.03% 164
2020
Q3
Sell
-3,199
Closed -$208K 154
2020
Q2
$208K Buy
+3,199
New +$201K 0.03% 133
2020
Q1
Sell
-3,199
Closed -$238K 133
2019
Q4
$238K Hold
3,199
0.04% 126
2019
Q3
$202K Buy
+3,199
New +$190K 0.04% 128
2019
Q1
Sell
-3,188
Closed -$209K 138
2018
Q4
$209K Sell
3,188
-47
-1% -$3.51K 0.04% 139
2018
Q3
$255K Buy
+3,235
New +$231K 0.06% 125

Other funds holding CVS

Pure Financial Advisors's CVS Position: Q2 2026 in Review

Pure Financial Advisors reduced its CVS Health (CVS) stake by 2.4% in Q2 2026, selling an estimated $15.4K and leaving 7,016 shares worth $726K. The position accounts for 0.01% of the portfolio, ranked #290.

Pure Financial Advisors first reported a position in CVS in Q3 2018 and has held it in 16 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Pure Financial Advisors held 7,016 shares of CVS Health worth $726K as of Q2 2026.
  • Pure Financial Advisors sold 172 CVS Health shares in Q2 2026, an estimated $15.4K.
  • CVS Health made up 0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #290 holding.
  • Pure Financial Advisors first reported a position in CVS Health in Q3 2018 and has held it in 16 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.